NCT07808320
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy
Clinical trial condition
Recurrent Ovarian Cancer
Explore clinical trials studying Recurrent Ovarian Cancer. Study availability and eligibility vary by location and protocol.
33 public trials
10 recruiting studies
Recurrent Ovarian Cancer trial results
Not yet recruiting
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
NCT07454018
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
Not specified
Not yet recruiting
Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer
NCT07286162
- Conditions
- Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Not yet recruiting
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
NCT06070285
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Power Life Sciences San Francisco, California, United States
Active, not recruiting
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
NCT06365853
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- University of California Los Angeles /ID# 269339 Los Angeles, California, United States
- Norton Cancer Institute - St. Matthews /ID# 269070 Louisville, Kentucky, United States
- Holy Cross Hospital - Silver Spring /ID# 269344 Silver Spring, Maryland, United States
- Mercy David C. Pratt Cancer Center /ID# 269350 St Louis, Missouri, United States
Active, not recruiting
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
NCT06107868
- Conditions
- Adnexal Diseases, Advanced Cancer, Endocrine Gland Neoplasms, +22 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, not recruiting
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
NCT05335993
- Conditions
- Adenocarcinoma of Ovary, Adnexal Diseases, Carcinoma, +25 more
- Locations
-
- Duke Cancer Center Durham, North Carolina, United States
- Stephenson Cancer Center- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
- University of Virginia Health System Charlottesville, Virginia, United States
NCT02195973
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT04457089
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
NCT03776812
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Site Reference ID/Investigator #004 Birmingham, Alabama, United States
- Site Reference ID/Investigator #038 Scottsdale, Arizona, United States
- Site Reference ID/Investigator #032 Denver, Colorado, United States
- Site Reference ID/Investigator #001 Chicago, Illinois, United States